FDA approves first topical treatment for vitiligo
The U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo.
Jul 21, 2022
0
31
The U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo.
Jul 21, 2022
0
31
A bionic eye being developed by a team of biomedical researchers at the University of Sydney and UNSW has shown to be safe and stable for long-term implantation in a three-month study, paving the way towards human trials.
Dec 1, 2021
0
202
Researchers have found an abnormal protein usually linked to a rare inherited form of motor neuron disease is present in all types of motor neuron disease, suggesting a common link between the different forms of the disease.
Aug 12, 2022
0
186
Twenty years after the release of the human genome, the genetic "blueprint" of human life, an international research team, including the University of British Columbia's Chris Overall, has now mapped the first draft sequence ...
Oct 19, 2020
0
257
A new drug has been found to be so effective against obesity that it may help patients avoid consequences such as diabetes and hypertension, according to a study published in the New England Journal of Medicine last week.
Feb 16, 2021
0
8
A revolutionary new way to give vaccines through microneedle skin patches is being tested at Swansea University, thanks to £200,000 of EU funding announced by the Welsh Government.
Aug 7, 2020
0
3
New research, published in the journal Diabetic Medicine, has revealed that children who develop type 1 diabetes (T1D) under the age of 12 activate genes involved in immune responses that does not occur in people who develop ...
Jul 5, 2023
0
13
Since its founding in 2016, Elon Musk's neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved ...
May 30, 2023
0
9
Canadian health authorities approved Thursday the first domestic COVID-19 vaccine, Quebec City-based biopharmaceutical firm Medicago and its partner GlaxoSmithKline announced.
Feb 24, 2022
0
5
Researchers from CSIRO, Australia's national science agency, have accomplished a world-first by processing one trillion points of genomic data through VariantSpark, an artificial intelligence-based platform, which can help ...
Sep 2, 2020
0
3